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After publication of the original article [1], the authors
noticed an error in the Competing interests section. The
sentence “MG received a research grant from Pfizer and
serves on an advisory board to Johnson & Johnson, man-
ufacturers of smoking cessation medications” should not
have been included in the section. As such, the correct
statement should be as follows:
Competing interests
SC has no competing interests to declare. LD has con-
ducted research for independent electronic cigarette
companies. These companies had no input into the de-
sign, conduct or write up of the projects. She has also
acted as a consultant for the pharmaceutical industry
and as an expert witness in a patent infringement case
(2015).
Further to this, the authors also noticed two small er-
rors, listed below:
1. The sentence beginning ‘Moreover, smoking
prevalence remains disproportionately…’ should
instead read as the following:
“Moreover, smoking prevalence remains dispropor-
tionately high in underrepresented (e.g. vulnerable/mar-
ginalised) groups (estimates of above 80% in those
dependent on illicit substances) [11], and the effectiveness
of e-cigarettes and other reduced risk nicotine-containing
products have not been extensively researched in these
groups.”
2. The sentence beginning ‘Why smokers with access
…’ should instead read as the following:* Correspondence: coxs15@lsbu.ac.uk
Centre for Addictive Behaviours Research, School of Applied Sciences
London South Bank University, 103 Borough Road, London SE1 0AA, UK
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the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/ze“Why smokers with access to reduced risk products
would still want to smoke and what factors encourage
complete switching to reduced harm products are key
areas requiring empirical investigation.”
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